Jubilant Pharmova Ltd. - Research Center
530019 JUBLPHARMA Group (A) BSE data
Results
|
Half yearly
|
Statement
|
|
More
|
|
Half yearly results in brief
(Rs crore)
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sep ' 20 |
Sales |
403.70 |
427.54 |
47.46 |
40.29 |
1,514.70 |
Operating profit |
5.00 |
2.93 |
-6.94 |
0.16 |
250.49 |
Interest |
13.50 |
7.29 |
15.91 |
14.68 |
66.93 |
Gross profit |
25.80 |
112.00 |
-7.17 |
95.67 |
205.43 |
EPS (Rs) |
0.09 |
5.44 |
-0.53 |
5.46 |
7.20 |
Half yearly
results in details
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sep ' 20 |
Other income |
34.30 |
116.36 |
15.68 |
110.19 |
21.87 |
Stock adjustment |
20.90 |
32.72 |
- |
- |
13.49 |
Raw material |
166.80 |
189.26 |
- |
- |
749.18 |
Power and fuel |
- |
- |
- |
- |
164.68 |
Employee expenses |
93.60 |
84.29 |
26.14 |
23.07 |
121.04 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
117.40 |
118.34 |
28.26 |
17.06 |
215.82 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
23.30 |
20.29 |
3.19 |
3.06 |
59.12 |
Taxation |
1.00 |
5.08 |
-1.91 |
5.66 |
31.64 |
Net profit / loss |
1.50 |
86.63 |
-8.45 |
86.95 |
114.67 |
Extra ordinary item |
- |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
15.90 |
15.93 |
15.93 |
15.93 |
15.93 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
1.24 |
0.69 |
-14.62 |
0.40 |
16.54 |
GPM (%) |
5.89 |
20.59 |
-11.36 |
63.58 |
13.37 |
NPM (%) |
0.34 |
15.93 |
-13.38 |
57.78 |
7.46 |